Related Experiment Video

Updated: May 31, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

[The decrease in morbidity and mortality of patients with chronic forms of ischemic heart disease is the result of

L Kotík1

  • 1I. Interní klinika Fakultní Thomayerovy nemocnice a IPVZ Praha. lubos.kotik@ftn.cz

Vnitrni Lekarstvi
|June 24, 2011
PubMed

Insights

For chronic coronary artery disease, lifestyle intervention is the most effective treatment for improving patient prognosis. Invasive methods like revascularization have not shown reduced morbidity or mortality in studies.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Context:

  • Chronic coronary artery disease (CAD) management remains a significant clinical challenge.
  • Current therapeutic strategies include invasive procedures and pharmacotherapy.
  • The long-term impact of these interventions on patient morbidity and mortality requires ongoing evaluation.

Purpose:

  • To compare the efficacy of various therapeutic methods for chronic coronary artery disease.
  • To evaluate the influence of different treatments on patient morbidity and mortality.
  • To highlight the prognostic value of lifestyle interventions versus invasive procedures.

Summary:

  • Large randomized studies indicate that invasive methods, such as percutaneous coronary intervention and surgical revascularization, do not significantly lower morbidity or mortality in chronic CAD patients.
  • Pharmacological treatments have repeatedly demonstrated their effectiveness in managing chronic CAD.
  • Lifestyle interventions, despite being the most cost-effective approach, show the greatest potential for improving prognosis in patients with chronic coronary artery disease.

Impact:

  • Findings challenge the routine reliance on invasive procedures for chronic CAD, suggesting a re-evaluation of treatment guidelines.
  • Emphasizes the underappreciated efficacy of lifestyle modifications in cardiovascular disease management.
  • Provides evidence for prioritizing cost-effective and accessible interventions to improve long-term outcomes for a large patient population.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...